Clinical trial
Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer (RADIT)
The purpose of this study is to determine whether the drug everolimus is effective in the treatment of patients with relapsed cancer of the testis.
| Category | Value |
|---|---|
| Study start date | 2010-11-16 |